LEEUWENHOEK LABORATORIES CO. LTD.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
Leeuwenhoek’s flagship product line is built around precision-health supplements that modulate the gut microbiome to support metabolic balance and overall well-being. They maintain one of the world’s largest next-generation Akkermansia strain repositories
The content above was translated by Ai
Founded Year
2021
Unified Business No.
91078929
Status
Active
Number of Employees
15
Total Paid-in
Capital
267,244,602 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Leeuwenhoek Laboratories Co., Ltd. was founded in August 2021 by a team of experts from National Taiwan University. The company is dedicated to researching and translating multi-omics microbiome science into health applications. By harnessing the power of microorganisms, it seeks to modulate the gut microbiota through evidence-based approaches to enhance metabolic health and support precision wellness.
The content above was translated by Ai
